28
Participants
Start Date
February 9, 2021
Primary Completion Date
January 31, 2025
Study Completion Date
December 31, 2025
Levetiracetam
Levetiracetam is currently approved in Australia and the U.S.A. for epilepsy. We will be providing levetiracetam in capsule form, 125mg levetiracetam in each capsule.
Placebo
Placebo intervention will be maize-starch filled capsules with identical physical features to the active capsules.
RECRUITING
University of Queensland Centre for Clinical Research, Brisbane
Queensland University of Technology
OTHER
Johns Hopkins University
OTHER
Cleveland Clinic Lou Ruvo Center for Brain Health
UNKNOWN
Royal Brisbane and Women's Hospital
OTHER_GOV
The University of Queensland
OTHER